Sommen; Francois Maria

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sommen; Francois Maria.The latest application filed is for "macrocylic pyridine derivatives".

Company Profile

0.16.19

Sommen; Francois Maria - Wortel BE
Sommen; Francois Maria - Beerse BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Macrocylic Pyridine Derivatives App 20170022201 - Diels; Gaston Stanislas Marcella ; et al.	2017-01-26
Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonists Grant 8,759,342 - Shyamali , et al. June 24, 2	2014-06-24
2-piperazin-1-yl-3H-imidazo[4,5-b]pyridine derivatives Grant 7,994,173 - Janssens , et al. August 9, 2	2011-08-09
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,795,261 - Janssens , et al. September 14, 2	2010-09-14
Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,572,786 - Janssens , et al. August 11, 2	2009-08-11
Respiratory syncytial virus replication inhibitors Grant 7,528,149 - Janssens , et al. May 5, 2	2009-05-05
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists Grant 7,514,424 - Janssens , et al. April 7, 2	2009-04-07
Amino-benzimidazoles Derivatives As Inhibitors Of Respiratory Syncytial Virus Replication App 20090036466 - Bonfanti; Jean-Francois ; et al.	2009-02-05
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,435,736 - Janssens , et al. October 14, 2	2008-10-14
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists Grant 7,410,970 - Janssens , et al. August 12, 2	2008-08-12
Respiratory syncytial virus replication inhibitors Grant 7,390,811 - Janssens , et al. June 24, 2	2008-06-24
Piperidine-amino-benzimidazole Derivatives As Inhibitors Of Respiratory Syncytial Virus Replication App 20080146613 - BONFANTI; Jean-Francois ; et al.	2008-06-19
Respiratory syncytial virus replication inhibitors Grant 7,361,657 - Janssens , et al. April 22, 2	2008-04-22
Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication Grant 7,355,051 - Bonfanti , et al. April 8, 2	2008-04-08
Novel Formulations For Opioid-Based Treatments Of Pain Comprising 1-(1,2-Disubstituted Piperidinyl)-4-Substituted Piperazine Derivatives App 20080070924 - Janssens; Frans Eduard ; et al.	2008-03-20
Urotensin II receptor antagonists App 20080039454 - Ghosh; Shyamali ; et al.	2008-02-14
Substituted homopiperidinyl benzimidazole analogues as fundic relaxants Grant 7,304,052 - Janssens , et al. December 4, 2	2007-12-04
Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists App 20070213346 - Janssens; Frans Eduard ; et al.	2007-09-13
Respiratory Syncytial Virus Replication Inhibitors App 20070135404 - Janssens; Frans Eduard ; et al.	2007-06-14
Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication App 20070093659 - Bonfanti; Jean-Francois ; et al.	2007-04-26
Respiratory syncytial virus replication inhibitors Grant 7,179,811 - Janssens , et al. February 20, 2	2007-02-20
Respiratory syncytial virus replication inhibitors Grant 7,173,034 - Janssens , et al. February 6, 2	2007-02-06
Respiratory syncytial virus replication inhibitors Grant 7,173,054 - Janssens , et al. February 6, 2	2007-02-06
Respiratory syncytial virus replication inhibitors App 20070021410 - Janssens; Frans Eduard ; et al.	2007-01-25
Respiratory Syncytial Virus Replication Inhibitors App 20070015747 - Janssens; Frans Eduard ; et al.	2007-01-18
Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists App 20060167008 - Janssens; Frans Eduard ; et al.	2006-07-27
Respiratory syncytial virus replication inhibitors App 20060154913 - Janssens; Frans Eduard ; et al.	2006-07-13
Novel formulations of opioid-based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives App 20060128721 - Janssens; Frans Eduard ; et al.	2006-06-15
Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists App 20060074069 - Janssens; Frans Eduard ; et al.	2006-04-06
Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists App 20060058285 - Janssens; Frans Eduard ; et al.	2006-03-16
Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists App 20060040950 - Janssens; Frans Eduard ; et al.	2006-02-23
Respiratory syncytial virus replication inhibitors App 20050234047 - Janssens, Frans Eduard ; et al.	2005-10-20
Substituted homopiperidinyl benzimidazole analogues as fundic relaxants App 20030139393 - Janssens, Frans Eduard ; et al.	2003-07-24
Fused imidazole derivatives as multidrug resistance modulators App 20030087895 - Janssens, Frans Eduard ; et al.	2003-05-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.